UNSPSC 85722820: Revision of autologous tissue substitute in left knee joint, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left knee joint, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWDX7Z

UNSPSC 85722820, Revision of autologous tissue substitute in left knee joint, external approach (Commodity), shows no relevant recent activity in state and local procurement. The code nominally describes a specific orthopedic surgical procedure—autologous tissue revision in the knee performed via external access—yet the six recent opportunities posted under this code span disability pension medical evaluations, surgical benefit carve-outs for public employee health plans, occupational medical surveillance for state ferry workers, emergency medical services for detained youth, pharmacy benefit management, and temporary clinical staffing. None involve autologous tissue procedures, knee joint revisions, or surgical implants. The mismatch between the code's clinical specificity and the actual procurement activity suggests either miscoding at the issuing-body level or a data-classification artifact with no bearing on orthopedic device or surgical-service suppliers.

The jurisdictions posting under this code include Arizona (City of Phoenix Retirement Office), California (City of Long Beach, County of Santa Clara Health System), Washington (Washington State Department of Transportation), and Texas (Harris County Juvenile Probation Department), along with Florida (Collier County Board of County Commissioners). These represent a mix of city, county, state, and regional health system buyers, but their solicitations address workforce medical screening, benefits administration, and clinical staffing rather than orthopedic procedures or tissue-substitute manufacturing. Vendors in autologous orthopedic tissue, knee implants, or surgical revision services should not pursue activity under this code without clarification from issuing bodies, as the posted opportunities do not reflect the commodity's intended scope.